AI Engines For more Details: Perplexity Kagi Labs You
Anti-inflammatory Effects: Fluocinolone acetonide works by suppressing the immune response and inhibiting the release of inflammatory mediators. This helps reduce inflammation, swelling, redness, and itching associated with various skin conditions.
Skin Conditions: Fluocinolone acetonide is commonly prescribed for the treatment of a wide range of inflammatory and pruritic (itchy) skin conditions, including eczema (atopic dermatitis), psoriasis, allergic dermatitis, contact dermatitis, seborrheic dermatitis, and other inflammatory disorders.
Eczema (Atopic Dermatitis): Eczema is a chronic inflammatory skin condition characterized by red, itchy, and inflamed patches of skin. Fluocinolone acetonide can help alleviate symptoms and improve the appearance of eczematous lesions by reducing inflammation and itching.
Psoriasis: Psoriasis is a chronic autoimmune skin disorder characterized by the rapid proliferation of skin cells, leading to the formation of thick, scaly plaques. Fluocinolone acetonide can help reduce inflammation, scaling, and redness associated with psoriatic lesions, providing symptomatic relief.
Allergic Dermatitis and Contact Dermatitis: Allergic dermatitis and contact dermatitis are inflammatory skin reactions caused by exposure to allergens or irritants, resulting in redness, itching, swelling, and sometimes blistering of the skin. Fluocinolone acetonide can help alleviate symptoms and promote healing in affected areas.
Dosage and Administration: The dosage and frequency of fluocinolone acetonide cream, ointment, solution, or gel depend on the specific skin condition being treated, the severity of symptoms, and the individual patient's response to treatment. It is typically applied thinly to the affected area(s) of the skin once or twice daily, as directed by a healthcare provider.
Duration of Treatment: Fluocinolone acetonide is usually prescribed for short-term use to control acute flare-ups of inflammatory skin conditions. Prolonged use of potent corticosteroids like fluocinolone acetonide may increase the risk of adverse effects, such as skin thinning, telangiectasia (dilation of blood vessels), and hypothalamic-pituitary-adrenal (HPA) axis suppression.
Side Effects: While fluocinolone acetonide is generally safe when used as directed, prolonged or excessive use may lead to local side effects, including skin atrophy (thinning), striae (stretch marks), perioral dermatitis (rash around the mouth), acneiform eruptions, and allergic contact dermatitis. Systemic absorption of fluocinolone acetonide may also cause systemic side effects, especially with prolonged use over large areas of the body or under occlusion.
Contraindications: Fluocinolone acetonide should not be used in patients with known hypersensitivity to corticosteroids or any other components of the medication. It should be used with caution in patients with certain skin conditions, such as acne, rosacea, perioral dermatitis, and skin infections, as it may exacerbate these conditions or delay healing.
Drug Interactions: There are no significant drug interactions reported with the topical use of fluocinolone acetonide. However, patients should inform their healthcare provider about all medications, supplements, and topical products they are using to avoid potential interactions or complications.
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| ADHD | 0.1 | 0.1 | |
| Age-Related Macular Degeneration and Glaucoma | 0.1 | 0.1 | |
| Allergic Rhinitis (Hay Fever) | 0.1 | 0.1 | |
| Allergy to milk products | 0.1 | 0.1 | |
| Alzheimer's disease | 0.1 | 0.1 | 0 |
| Ankylosing spondylitis | 0.1 | -0.1 | |
| Anorexia Nervosa | 0.1 | -0.1 | |
| Antiphospholipid syndrome (APS) | 0.1 | 0.1 | |
| Asthma | 0.1 | -0.1 | |
| Atherosclerosis | 0.2 | -0.2 | |
| Atrial fibrillation | 0.1 | 0.1 | 0 |
| Autism | 0.1 | 0.1 | 0 |
| Bipolar Disorder | 0.1 | 0.1 | 0 |
| Brain Trauma | 0.1 | -0.1 | |
| Carcinoma | 0.1 | 0.1 | 0 |
| Celiac Disease | 0.1 | 0.1 | 0 |
| Cerebral Palsy | 0.1 | -0.1 | |
| Chronic Fatigue Syndrome | 0.2 | 0.1 | 1 |
| Chronic Kidney Disease | 0.1 | 0.1 | 0 |
| Chronic Lyme | 0.1 | -0.1 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.1 | -0.1 | |
| Coagulation / Micro clot triggering bacteria | 0.1 | -0.1 | |
| Colorectal Cancer | 0.1 | 0.1 | |
| Constipation | 0.1 | 0.1 | 0 |
| COVID-19 | 0.1 | 0.2 | -1 |
| Crohn's Disease | 0.1 | 0.1 | 0 |
| cystic fibrosis | 0.1 | -0.1 | |
| deep vein thrombosis | 0.1 | -0.1 | |
| Depression | 0.5 | 0.1 | 4 |
| Endometriosis | 0.1 | 0.1 | |
| Epilepsy | 0.1 | 0.1 | 0 |
| Fibromyalgia | 0.1 | 0.1 | 0 |
| Functional constipation / chronic idiopathic constipation | 0.2 | 0.1 | 1 |
| gallstone disease (gsd) | 0.1 | -0.1 | |
| Generalized anxiety disorder | 0.1 | -0.1 | |
| Graves' disease | 0.1 | 0.1 | 0 |
| Halitosis | 0.1 | 0.1 | |
| Hashimoto's thyroiditis | 0.1 | 0.1 | 0 |
| Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.1 | 0.1 | |
| hyperglycemia | 0.1 | -0.1 | |
| hypertension (High Blood Pressure | 0.1 | 0.1 | 0 |
| Hypoxia | 0.1 | 0.1 | |
| Inflammatory Bowel Disease | 0.1 | 0.2 | -1 |
| Insomnia | 0.1 | 0.1 | 0 |
| Intracranial aneurysms | 0.1 | 0.1 | |
| Irritable Bowel Syndrome | 0.1 | 0.1 | 0 |
| Liver Cirrhosis | 0.1 | 0.1 | 0 |
| Long COVID | 0.1 | 0.1 | 0 |
| Low bone mineral density | 0.1 | -0.1 | |
| ME/CFS with IBS | 0.1 | -0.1 | |
| ME/CFS without IBS | 0.1 | 0.1 | 0 |
| Metabolic Syndrome | 0.1 | 0.1 | 0 |
| Mood Disorders | 0.5 | 0.1 | 4 |
| Multiple Sclerosis | 0.1 | -0.1 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.1 | -0.1 | |
| Obesity | 0.1 | 0.1 | 0 |
| obsessive-compulsive disorder | 0.1 | 0.1 | 0 |
| Osteoarthritis | 0.1 | 0.1 | |
| Osteoporosis | 0.1 | 0.1 | 0 |
| Parkinson's Disease | 0.2 | -0.2 | |
| Polycystic ovary syndrome | 0.1 | 0.1 | 0 |
| Psoriasis | 0.1 | -0.1 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.1 | 0.1 | 0 |
| Rosacea | 0.1 | -0.1 | |
| Schizophrenia | 0.1 | 0.1 | 0 |
| Sjögren syndrome | 0.1 | -0.1 | |
| Sleep Apnea | 0.1 | -0.1 | |
| Stress / posttraumatic stress disorder | 0.1 | 0.1 | 0 |
| Systemic Lupus Erythematosus | 0.1 | 0.1 | 0 |
| Tourette syndrome | 0.1 | -0.1 | |
| Type 1 Diabetes | 0.1 | 0.1 | 0 |
| Type 2 Diabetes | 0.1 | 0.1 | 0 |
| Ulcerative colitis | 0.1 | 0.1 | 0 |
| Unhealthy Ageing | 0.1 | 0.1 | 0 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.